Sanofi (NYSE:SNY) is a healthcare company. It focuses on pharmaceuticals and vaccines. It offers a range of life-saving vaccines and therapeutic treatments for conditions in immunology, oncology, neurology, rare blood disorders, and rare diseases, as well as consumer healthcare products. Its products are designed to improve people's lives by addressing complex medical challenges and advancing health. It was founded in 1973 and is based in Gentilly, France.

Boehringer Ingelheim operates as a biopharmaceutical company. The company's main offerings include therapies in areas of high unmet medical need, spanning three business areas such as human pharma, animal health, and biopharmaceutical contract manufacturing. It primarily serves the pharmaceutical and healthcare industries. The company was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Servier is a global pharmaceutical company focused on therapeutic progress to serve patient needs across various medical domains including cardiology and oncology. The company offers a range of targeted therapies and generic drugs aimed at treating cardiovascular diseases, cancers, and immuno-inflammatory and neuro-psychiatric conditions. Servier's research and development efforts prioritize innovative treatments in oncology, neuroscience, and immuno-inflammatory diseases, with a commitment to precision medicine and quality care for all. It was founded in 1954 and is based in Suresnes, France.

Sumitomo Pharma is a biopharmaceutical company focused on developing therapeutic and scientific breakthroughs. The company's main offerings include the development of novel cancer therapeutics and a robust pipeline of treatments aimed at addressing unmet clinical needs in oncology. Sumitomo Pharma was formerly known as Sumitomo Dainippon Pharma. It was founded in 1897 and is based in Osaka, Japan.

LifeArc operates as a self-financing medical research charity. The organization specializes in drug discovery, diagnostics development, antibody humanization, and intellectual property management, aiming to lab-based scientific discoveries into diagnostics, treatments, and cures. LifeArc collaborates with various sectors including the pharmaceutical industry, biotechnology sector, and academic institutions to develop and commercialize medical research. LifeArc was formerly known as MRC Technology. It was founded in 2000 and is based in London, United Kingdom.

Daiichi Sankyo France operates as a global pharmaceutical company with a focus on providing therapeutic solutions in oncology and cardiology. The company offers treatments for various diseases including hypertension, dyslipidemia, diabetes, acute coronary syndrome, venous thromboembolism, breast cancer, metastatic melanoma, inflammatory diseases, and pain. Daiichi Sankyo France primarily serves the healthcare sector, providing innovative medications and supporting services to patients and medical professionals. It was founded in 2003 and is based in Rueil-Malmaison, France.